Marchetti A, Pellegrini S, Sozzi G, Bertacca G, Gaeta P, Buttitta F, Carnicelli V, Griseri P, Chella A, Angeletti C A, Pierotti M, Bevilacqua G
Department of Oncology, University of Pisa, Italy.
Br J Cancer. 1998 Jul;78(1):73-8. doi: 10.1038/bjc.1998.445.
Lung cancer is strictly associated with tobacco smoking. Tumours developed in non-smoking subjects account for less than 10% of all lung cancers and show peculiar histopathological features, being prevalently adenocarcinomas. A number of genetic data suggest that their biological behaviour may be different from that of lung tumours caused by smoking, however the number of cases investigated to date is too low to draw definitive conclusions. We have examined the status of p53 and K-ras genes and the presence of loss of heterozygosity (LOH) at the FHIT locus in a series of 35 lung adenocarcinomas that developed in subjects who had never smoked. Results were compared with those obtained in a series of 35 lung adenocarcinomas from heavy-smoking subjects. In the group of non-smoking subjects p53 mutations and LOH at the FHIT locus were present in seven (20%) cases, and the two alterations were constantly associated (P < 0.0001), whereas they were not related in the series of carcinomas caused by smoking. In tumours developed in heavy-smoking subjects, the frequency of LOH at the FHIT locus was significantly higher (P = 0.006) than in tumours from non-smoking subjects. The frequency of p53 mutations in adenocarcinomas caused by smoking was not different from that seen in non-smoking subjects. However, in the group of smoking subjects we observed mostly G:C --> T:A transversions, whereas frameshift mutations and G:C --> A:T transitions were more frequently found in tumours from non-smoking subjects. No point mutations of the K-ras gene at codon 12 were seen in subjects who had never smoked, whereas they were present (mostly G:C --> T:A transversions) in 34% of tumours caused by smoking (P = 0.002). Our data suggest that lung adenocarcinomas developed in subjects who had never smoked represent a distinct biological entity involving a co-alteration of the p53 gene and the FHIT locus in 20% of cases.
肺癌与吸烟密切相关。非吸烟患者中发生的肿瘤占所有肺癌的比例不到10%,且具有独特的组织病理学特征,主要为腺癌。大量基因数据表明,它们的生物学行为可能与吸烟所致的肺部肿瘤不同,然而,迄今为止所研究的病例数量过少,无法得出明确结论。我们检测了35例从不吸烟患者所患肺腺癌中p53和K-ras基因的状态以及FHIT基因座杂合性缺失(LOH)的情况。将结果与35例重度吸烟患者所患肺腺癌的检测结果进行了比较。在非吸烟组中,7例(20%)病例存在p53突变和FHIT基因座的LOH,且这两种改变始终相关(P<0.0001),而在吸烟所致的癌组中它们并无关联。在重度吸烟患者所患肿瘤中,FHIT基因座的LOH频率显著高于非吸烟患者的肿瘤(P = 0.006)。吸烟所致腺癌中p53突变的频率与非吸烟患者所见无异。然而,在吸烟组中,我们大多观察到G:C→T:A颠换,而移码突变和G:C→A:T转换在非吸烟患者的肿瘤中更为常见。在从不吸烟的患者中未发现K-ras基因第12密码子的点突变,而在吸烟所致的肿瘤中有34%存在该突变(大多为G:C→T:A颠换)(P = 0.002)。我们的数据表明,从不吸烟患者所患肺腺癌代表一种独特的生物学实体,20%的病例涉及p53基因和FHIT基因座的共同改变。